Bhuiyan Mohammad Mahtab Uddin

Fujimoto K

Jae Youl Cho

Jong-Hoon Kim

Laila Anjuman Banu

Md. Abdullah Yusuf

Mohammad Faisal Haidere

Mojica FJ.

Ratan ZA

Sojib Bin Zaman

Stewart B

Young-Jin Son

Yu L

Zubair Ahmed Ratan

 Bacteria and archaea possess adaptive immunity against foreign genetic materials through clustered regularly interspaced short palindromic repeat (CRISPR) systems. The discovery of this intriguing bacterial system heralded a revolutionary change in the field of medical science. The CRISPR and CRISPR-associated protein 9 (Cas9) based molecular mechanism has been applied to genome editing. This CRISPR-Cas9 technique is now able to mediate precise genetic corrections or disruptions in in vitro and in vivo environments. The accuracy and versatility of CRISPR-Cas have been capitalized upon in biological and medical research and bring new hope to cancer research. Cancer involves complex alterations and multiple mutations, translocations and chromosomal losses and gains. The ability to identify and correct such mutations is an important goal in cancer treatment. In the context of this complex cancer genomic landscape, there is a need for a simple and flexible genetic tool that can easily identify functional cancer driver genes within a comparatively short time. The CRISPR-Cas system shows promising potential for modeling, repairing and correcting genetic events in different types of cancer. This article reviews the concept of CRISPR-Cas, its application and related advantages in oncology. </jats:p

Crossref

Therapeutic Advances in Medical Oncology

CRISPR-Cas9: a promising genetic engineering approach in cancer research

CRISPR-Cas9: a promising genetic engineering approach in cancer research

Abstract

Similar works

Full text

Available Versions

Crossref